Key takeaways
Epzicom (abacavir/lamivudine) and Triumeq (abacavir/dolutegravir/lamivudine) are both used to treat HIV, but they have some key differences. Epzicom combines two antiretrovirals (abacavir and lamivudine), while Triumeq includes an additional third antiretroviral, dolutegravir. This makes Triumeq a complete single-tablet regimen for HIV treatment, whereas Epzicom needs to be taken with other HIV medications. Triumeq is available in both tablet form and as a dissolvable tablet for children, while Epzicom is only available as a tablet for adults. Both medications require a genetic test before starting to check for a risk of severe allergic reactions. Epzicom is available as a generic, which can be more affordable, while Triumeq does not have a generic form. Additionally, Triumeq has more interactions with other medications and may be less prefered during pregnancy.
